ARTAH Nutrition has secured £2.85m in investments to accelerate its growth as a dietary supplement brand.
The funding will primarily go towards the company's global expansion and product development initiatives, while also contributing to the company's digital growth.
By obtaining this investment from Five Seasons Ventures (FSV), ARTAH plans to bring their product portfolio to the EU market.
Once the product line has reached the European market, the dietary supplement company will invest in product development and clinical trials to validate the efficacy of its portfolio.
Since its launch in 2021, ARTAH has expanded its reach into the supplement market significantly — partering with companies like Selfridges and Wholefoods Market UK to bring its science-backed solutions to the British public.
Rhian Stephenson, Founder of ARTAH said: "Our bodies have an amazing ability to thrive, but in today's food environment, this is becoming increasingly difficult; with the drastically reduced nutrient content of food, the effects of food processing, environmental changes and the physiological demands of our modern lifestyle, there are big nutrient gaps; we simply aren’t getting what we need."
"Only 12% of the population are metabolically healthy,1 so functional foods and high-quality supplements are essential tools for the maintenance and optimisation of health."
Niccolo Manzoni, Founding Partner at Five Seasons Ventures, highlighted: 'We are proud to be partnering with Rhian and the ARTAH team to empower people to take control of their health and wellbeing. ARTAH is a first mover in the metabolic health category and has the knowledge and vision to become the category leader in the space."
"The company operates in a unique area of the high growth supplements market by meeting consumer demand in digestive health, metabolic health, cellular health and longevity, and pulling it all together with nutrition. Having witnessed Rhian successfully build Psycle into a recognised and trusted brand across the UK fitness space, we are confident in her expertise to once again address an important area of health.’